The contribution of DC in CXCL9/10-DC-induced antitumor effects via enhanced tumor antigen presentation and broader tumor-specific T cell activation will be evaluated in future studies, including therapy-induced changes in T cell receptor (TCR) clonality by longitudinal TCR sequencing as well as tumor immunoediting by whole exosome sequencing, as previously described.54 Here, CXCL9 is linked to neoplasm.